Urica Therapeutics, a Fortress Biotech subsidiary company focused on the development and commercialization of pharmaceutical products to treat gout and chronic 3 October 2022
As with any big pharma company, Swiss giant Novartis periodically holds events to inform shareholders and other interested parties on its updated strategy and o 22 September 2022
French firm Sanofi.US healthcare conglomerate Johnson & Johnson.the UK’s GSK.its former consumer healthcare unit Haleon.privately-held Boehringer Ingelheim and 12 August 2022
Amneal Pharmaceuticals has announced that it has received Abbreviated New Drug Application (ANDA) approval from the US Food and Drug Administration (FDA) for fo 12 August 2022
Pfizer has announced that an interim futility analysis of the global Phase III trial which indicates that the trial unlikely to meet primary endpoint. 5 August 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.